Remove virpax-pharmaceuticals-engages-new-england-investors-to-direct-licensing-strategy-for-envelta-in-china
article thumbnail

Virpax Pharmaceuticals Engages New England Investors to Direct Licensing Strategy for Envelta™ in China

Medical Marijuana Program Connection

–(BUSINESS WIRE)–Virpax® Pharmaceuticals, Inc. Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain. BERWYN, Pa.–(BUSINESS Read More